Compass Pathways PLC

Compass Pathways PLC is a biotechnology company focused on developing innovative treatments for mental health disorders. The company is particularly known for its work in advancing the use of psilocybin therapy, a psychedelic compound, for treatment-resistant depression. By conducting rigorous clinical trials and research, Compass Pathways aims to provide evidence-based solutions that can be integrated into existing healthcare systems to improve patient outcomes. The company's approach combines scientific research with a commitment to regulatory compliance, aiming to bring new therapeutic options to market that address unmet needs in mental health care.